Projected Income Statement: Lundbeck

Forecast Balance Sheet: Lundbeck

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,043 2,031 -711 12,182 8,221 4,003 -182 -3,953
Change - -33.26% -135.01% 1,813.36% -32.52% -51.31% -104.55% -2,071.98%
Announcement Date 2/9/22 2/7/23 2/7/24 2/5/25 2/4/26 - - -
1DKK in Million
Estimates

Cash Flow Forecast: Lundbeck

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 610 820 501 565 618 583.4 589.7 578.6
Change - 34.43% -38.9% 12.77% 9.38% -5.6% 1.08% -1.89%
Free Cash Flow (FCF) 1 1,662 2,699 3,579 2,761 4,863 6,008 6,072 5,586
Change - 62.39% 32.6% -22.86% 76.13% 23.54% 1.07% -8.01%
Announcement Date 2/9/22 2/7/23 2/7/24 2/5/25 2/4/26 - - -
1DKK in Million
Estimates

Forecast Financial Ratios: Lundbeck

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 22.82% 25.56% 28.38% 28.84% 32% 31.63% 31.71% 30.55%
EBIT Margin (%) 12.33% 15.63% 16.05% 14.86% 21.42% 23.7% 24.08% 23.08%
EBT Margin (%) 9.7% 13.56% 15.03% 16.9% 18.22% 22.69% 23.17% 22.73%
Net margin (%) 8.09% 10.5% 11.5% 14.28% 12.96% 17.7% 17.69% 16.83%
FCF margin (%) 10.2% 14.79% 17.97% 12.55% 19.74% 23.19% 23.32% 21.91%
FCF / Net Income (%) 126.1% 140.87% 156.29% 87.85% 152.35% 131.03% 131.89% 130.14%

Profitability

        
ROA 7.07% 8.87% 6.12% 6.66% 6.13% 7.96% 7.6% 6.99%
ROE 14.17% 16.37% 10.7% 13.4% 20.93% 18.81% 16.3% 13.75%

Financial Health

        
Leverage (Debt/EBITDA) 0.82x 0.44x - 1.92x 1.04x 0.49x - -
Debt / Free cash flow 1.83x 0.75x - 4.41x 1.69x 0.67x - -

Capital Intensity

        
CAPEX / Current Assets (%) 3.74% 4.49% 2.52% 2.57% 2.51% 2.25% 2.27% 2.27%
CAPEX / EBITDA (%) 16.4% 17.59% 8.86% 8.9% 7.84% 7.12% 7.14% 7.43%
CAPEX / FCF (%) 36.7% 30.38% 14% 20.46% 12.71% 9.71% 9.71% 10.36%

Items per share

        
Cash flow per share 1 - 3.54 4.11 3.35 5.52 6.161 6.545 6.268
Change - - 16.1% -18.49% 64.78% 11.62% 6.23% -4.23%
Dividend per Share 1 - 0.58 0.7 0.95 1.15 1.552 1.397 1.515
Change - - 20.69% 35.71% 21.05% 34.96% -10% 8.5%
Book Value Per Share 1 - 20.93 22.22 25.23 25.1 28.81 32.03 34.96
Change - - 6.16% 13.55% -0.52% 14.77% 11.2% 9.13%
EPS 1 - 1.93 2.31 3.17 3.22 4.54 4.613 4.381
Change - - 19.69% 37.23% 1.58% 40.99% 1.6% -5.03%
Nbr of stocks (in thousands) - 992,840 992,840 992,011 991,227 991,227 991,227 991,227
Announcement Date - 2/7/23 2/7/24 2/5/25 2/4/26 - - -
1DKK
Estimates
2026 *2027 *
P/E 9.37x 9.23x
PBR 1.48x 1.33x
EV / Sales 1.77x 1.6x
Yield 3.65% 3.28%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
42.56DKK
Average target price
49.12DKK
Spread / Average Target
+15.40%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!